Zacks highlights Cigna (CI) as a stock to watch with a #3 (Hold) rank and VGM Score of A. The company shows solid growth prospects with a Growth Style Score of B and forecasted year-over-year earnings growth of 2.3% for the current fiscal year. Two analysts revised earnings estimates higher in the last 60 days, with the consensus estimate increasing to $30.51 per share.

CVS Health's Pharmacy & Consumer Wellness segment showed strong growth with operating income up 10.2% year-over-year to $1.48 billion in Q2 2026, supported by higher prescription volumes and improved margins. The company raised its 2026 operating income outlook for the segment by $220 million. CVS is expanding AI tools including Health100 and Claims Assist Manager to improve efficiency and customer service. However, reimbursement pressure, regulatory scrutiny, and insufficient Medicare Advantage payment updates remain key headwinds. With a discounted valuation (P/S of 0.29X vs. industry average 0.53X), Zacks recommends current holders maintain positions while prospective investors wait for a more favorable entry point.

BrightSpring Health Services (BTSG) reported strong Q2 2026 results with Specialty and Infusion revenue growing 30% and scripts rising 31%, driven by branded limited distribution drugs (LDDs) and expansion into rare and orphan therapies. The company added two new LDDs, bringing its portfolio to 155 programs with 12 launched in 2026. Pharmacy Solutions adjusted EBITDA increased 44% to $180 million. Peers Cigna and Humana also showed strength in specialty pharmacy segments, though with different growth drivers.

Cigna Healthcare is introducing Smart Coverage, a new benefit option that automatically links medical claims with supplemental benefits to provide eligible members up to $7,000 for covered health events. The program launches January 1, 2027, for mid-sized employers and addresses a significant affordability gap, with nearly 60% of Americans unprepared for health costs. The initiative is designed to increase enrollment in high-deductible plans and boost supplemental product participation.

The Dolphin Company's management has proposed selling its Mexican assets to Delphinus Blue Planet (Grupo Xcaret subsidiary) for $20 million, a deal that would violate Mexican Supreme Court rulings and create a 90% monopoly in dolphin habitat tourism. The proposal was filed in U.S. Bankruptcy Court despite an active judicial stay from Mexico's highest court prohibiting asset sales without authorization.

Vanguard research forecasts that U.S. value stocks and small-cap stocks will outperform growth stocks over the next 10 years. The article compares two Vanguard ETFs for value stock exposure: the Vanguard Small-Cap Value ETF (VBR), a passively managed fund with ultra-low fees, and the Vanguard U.S. Value Factor ETF (VFVA), an actively managed alternative with broader market-cap exposure. Both funds have recently outperformed the S&P 500 and Nasdaq-100.

Modern Therapy Group has launched a virtual intensive outpatient program (IOP) for adults with depression, anxiety, trauma, and other mental health conditions. The program offers five days a week of clinician-led telehealth treatment, providing a middle ground between weekly therapy and inpatient care. Available in seven states with in-network coverage from major insurers including Blue Cross Blue Shield, Aetna, Cigna, and Optum/United.

The Global Initiative on Loneliness and Connection (GILC) is hosting the Global Connection Forum on June 17, 2026, to address social disconnection as a major public health and economic challenge. The forum will bring together leaders from public health, policy, and philanthropy to explore how social connection can repair polarization and division. Research shows chronic disconnection increases illness risk by 26-28% and costs employers $159 billion annually in lost productivity.

Cigna reported Q1 2026 adjusted earnings of $7.79 per share, beating consensus of $7.61, with sales rising 5% to $68.52 billion. The company raised its full-year adjusted EPS outlook to at least $30.35. However, Cigna announced plans to exit the individual exchange business by year-end and initiated a strategic review of eviCore. CEO David Cordani will transition to Executive Chair, with Brian Ivanko becoming CEO in July 2026.

The Cigna Group's Board of Directors declared a quarterly cash dividend of $1.56 per share, payable on June 18, 2026, to shareholders of record as of June 4, 2026.

Boone Capital Management liquidated its entire $13.57 million stake in Cogent Biosciences (945,042 shares) in Q4 2026, despite the stock surging 372% over the past year. The fund reallocated capital to earlier-stage biotech opportunities like TYRA, which has gained 40% in 2026, suggesting a strategic shift toward higher-risk, higher-upside clinical-stage investments.

Ushur announced Voice-Guided Experience, a new capability that enables organizations in regulated industries to guide customers through complex workflows using synchronized voice and mobile interactions. The AI-powered feature keeps voice conversations active while opening a synchronized mobile experience, allowing customers to speak or tap without switching channels. The platform supports 74 languages, maintains enterprise-grade compliance (HITRUST r2, SOC 2, HIPAA), and is designed to improve completion rates and reduce operational burden for healthcare, insurance, and financial services organizations.